Home › Changes to late-stage breast cancer trial sends shares of Celldex plunging
 

Keywords :   


Changes to late-stage breast cancer trial sends shares of Celldex plunging

2014-11-06 01:48:08| Biotech - Topix.net

It wasn't the financial picture at Celldex Therapeutics that sent investors running today. Rather, it was the news that a trial of one its two lead cancer drugs will last longer than hoped that sent its shares down 20 percent as of 2 p.m. today.

Tags: trial cancer shares breast

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
29.09Hurricane Isaac Graphics
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Forecast Discussion Number 14
29.09Tropical Storm Joyce Forecast Discussion Number 8
29.09Hurricane Isaac Public Advisory Number 14
29.09Summary for Hurricane Isaac (AT5/AL102024)
More »